331 related articles for article (PubMed ID: 11205420)
1. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.
Duxon MS; Stretton J; Starr K; Jones DN; Holland V; Riley G; Jerman J; Brough S; Smart D; Johns A; Chan W; Porter RA; Upton N
Psychopharmacology (Berl); 2001 Jan; 153(2):203-9. PubMed ID: 11205420
[TBL] [Abstract][Full Text] [Related]
2. Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity.
Jones DN; Gartlon J; Parker F; Taylor SG; Routledge C; Hemmati P; Munton RP; Ashmeade TE; Hatcher JP; Johns A; Porter RA; Hagan JJ; Hunter AJ; Upton N
Psychopharmacology (Berl); 2001 Jan; 153(2):210-8. PubMed ID: 11205421
[TBL] [Abstract][Full Text] [Related]
3. Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades.
Spinazzi R; Ziolkowska A; Neri G; Nowak M; Rebuffat P; Nussdorfer GG; Andreis PG; Malendowicz LK
Int J Mol Med; 2005 May; 15(5):847-52. PubMed ID: 15806308
[TBL] [Abstract][Full Text] [Related]
4. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats.
Rodgers RJ; Halford JC; Nunes de Souza RL; Canto de Souza AL; Piper DC; Arch JR; Upton N; Porter RA; Johns A; Blundell JE
Eur J Neurosci; 2001 Apr; 13(7):1444-52. PubMed ID: 11298806
[TBL] [Abstract][Full Text] [Related]
5. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
[TBL] [Abstract][Full Text] [Related]
6. Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor.
Ziolkowska A; Spinazzi R; Albertin G; Nowak M; Malendowicz LK; Tortorella C; Nussdorfer GG
J Steroid Biochem Mol Biol; 2005 Sep; 96(5):423-9. PubMed ID: 16157481
[TBL] [Abstract][Full Text] [Related]
7. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem.
Sunter D; Morgan I; Edwards CM; Dakin CL; Murphy KG; Gardiner J; Taheri S; Rayes E; Bloom SR
Brain Res; 2001 Jul; 907(1-2):27-34. PubMed ID: 11430882
[TBL] [Abstract][Full Text] [Related]
8. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats.
Haynes AC; Jackson B; Chapman H; Tadayyon M; Johns A; Porter RA; Arch JR
Regul Pept; 2000 Dec; 96(1-2):45-51. PubMed ID: 11102651
[TBL] [Abstract][Full Text] [Related]
9. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus.
Soffin EM; Evans ML; Gill CH; Harries MH; Benham CD; Davies CH
Neuropharmacology; 2002 Jan; 42(1):127-33. PubMed ID: 11750922
[TBL] [Abstract][Full Text] [Related]
10. Orexinergic neurons and barbiturate anesthesia.
Kushikata T; Hirota K; Yoshida H; Kudo M; Lambert DG; Smart D; Jerman JC; Matsuki A
Neuroscience; 2003; 121(4):855-63. PubMed ID: 14580935
[TBL] [Abstract][Full Text] [Related]
11. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.
Kennett GA; Wood MD; Bright F; Trail B; Riley G; Holland V; Avenell KY; Stean T; Upton N; Bromidge S; Forbes IT; Brown AM; Middlemiss DN; Blackburn TP
Neuropharmacology; 1997; 36(4-5):609-20. PubMed ID: 9225286
[TBL] [Abstract][Full Text] [Related]
12. Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test.
Yamamoto T; Saito O; Shono K; Hirasawa S
Eur J Pharmacol; 2003 Nov; 481(2-3):175-80. PubMed ID: 14642783
[TBL] [Abstract][Full Text] [Related]
13. Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and growth of tumor cells.
Spinazzi R; Rucinski M; Neri G; Malendowicz LK; Nussdorfer GG
J Clin Endocrinol Metab; 2005 Jun; 90(6):3544-9. PubMed ID: 15797953
[TBL] [Abstract][Full Text] [Related]
14. Orexin receptor subtype activation and locomotor behaviour in the rat.
Samson WK; Bagley SL; Ferguson AV; White MM
Acta Physiol (Oxf); 2010 Mar; 198(3):313-24. PubMed ID: 19889100
[TBL] [Abstract][Full Text] [Related]
15. m-CPP-induced self-grooming is mediated by 5-HT2C receptors.
Graf M; Kantor S; Anheuer ZE; Modos EA; Bagdy G
Behav Brain Res; 2003 Jun; 142(1-2):175-9. PubMed ID: 12798279
[TBL] [Abstract][Full Text] [Related]
16. Orexin 2 receptor is involved in orexin A-induced hyperlocomotion in rats.
Maehara S; Furukawa J; Ota T
Pharmacol Rep; 2019 Dec; 71(6):1147-1150. PubMed ID: 31655279
[TBL] [Abstract][Full Text] [Related]
17. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
[TBL] [Abstract][Full Text] [Related]
18. Orexins/hypocretins: pain regulation and cellular actions.
Chiou LC; Lee HJ; Ho YC; Chen SP; Liao YY; Ma CH; Fan PC; Fuh JL; Wang SJ
Curr Pharm Des; 2010; 16(28):3089-100. PubMed ID: 20687883
[TBL] [Abstract][Full Text] [Related]
19. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
[TBL] [Abstract][Full Text] [Related]
20. Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain.
Cheng JK; Chou RC; Hwang LL; Chiou LC
J Pharmacol Exp Ther; 2003 Dec; 307(3):1065-71. PubMed ID: 14551290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
